R
Rubicon Research Ltd
PharmaceuticalsSmallcap
About the company
Rubicon Research Ltd is a pharmaceutical formulations company focused on R&D of specialty and drug-device combination products for regulated markets, especially the US, offering multiple dosage forms and therapeutic areas including analgesics, CVS, CNS, gastrointestinal, and respiratory products.
Performance
- Stock
- Loading Stock value
—
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 94.10 | 34.78 |
| PB Ratio | 23.37 | 5.49 |
| Dividend Yield | 0.00% | 0.61% |
Understand what these metrics mean.
Peer Stocks
For peer comparison & financials,
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions